A new study shows that even in the first week of use, commonly used
analgesics such as Motrin, Advil and Aleve may also increase the risk of
heart attack.
The researchers found that, in general, these drugs and other drugs
known as nonsteroidal antiinflammatory drugs (NSAIDs) would increase the
risk of heart attack by 20% to 50% compared to those who did not use
them.
However, for most people, this is only a small increase in the risk - about 1% per year, the researchers said.
However,
from a public health point of view, the increase in the risk of heart
attack is even small, because the use of non-steroidal anti-inflammatory
drugs is very common, "chief researcher Michelle Bally (Michele Bally)
said she Is an epidemiologist at the Montreal Hospital Research Center.
Increased risk of heart attack associated with NSAID was observed at any dose of one week, one month, or more than one month. The study found that the risk increased with the dose increase.
NSAIDs are widely used to treat pain and inflammation in long term conditions such as arthritis and other joint disorders. Bally said many people also had short-term problems such as menstrual
cramps, colds or flu fever, and occasional back pain or headaches.
She pointed out that the study does not actually prove that NSAIDs cause the possibility of heart attack.
"This is an observational study based on prescription or distribution
of drugs, and not all potential influencing factors can be taken into
account," Bally said.
"Although this means that the causal relationship can not be
concluded, but the study is the largest type of investigation, it is
based on real life in the observation.
Taking this into account, Bally and her team expressed the need for careful use of NSAIDS.
To reduce the likelihood of heart injury, she recommends taking into
account all available treatment regimens and then deciding to treat
occasional pain, fever or inflammation.
Read the NSAID drug label and use the lowest possible effective dose,
Bally join Bally, who was studying at the University of Montreal at
McGill University.
And the study did not involve a very common, less effective NSAID: low-dose aspirin. Numerous well-designed trials have found that daily "baby aspirin" can
help contain the possibility of dangerous people on dangerous heart
events.
For the study, Bally and her colleagues analyzed four previously published studies, of which nearly 447,000 were present. More than 61,400 people were suffering from a heart attack.
In this type of study, called meta-analysis, researchers try to find common trends in different studies.
Researchers studied NSAIDs such as Motrin, Advil, Aleve, Voltaren, Celebrex, and Roixichet (Vioxx). Vioxx was pulled from the US market in 2004 because it increased the risk of heart attack and stroke.
Bally said the risk of heart attack associated with NSAIDs was the highest in the first month of use.
The researchers found that in the first 30 days, the daily dose of
more than 1,200 mg (mg) of ibuprofen and more than 750 mg of naproxen
was particularly harmful"Using NSAID for more than a month, this high risk does not seem to increase further," Bally said. "But we did not repeat the heart attack."
In general, patients with heart disease or heart risk factors are more
likely to develop heart attacks after NSAID use than patients without
these risk factors, she said.
Bally said patients should be aware of their own heart disease risk and discuss with their physician the use of NSAID.
"People who take these drugs to treat chronic pain disorders may want
to consider whether increasing the therapeutic effect can increase the
risk of a heart attack," Bally said.
According to this new study and other tests, California heart experts believe that patients should not ignore these drugs.
"Randomized trials and observations show that the use of NSAIDs
increases the risk of heart attacks and other types of cardiovascular
events," said Dr. Gregg Fonarow. "He is a professor of cardiology at the
University of California, Los Angeles.
Fonarow
said: "The absolute risk is very small, but everyone considering the
use of these drugs should carefully weigh the benefits of this increase
in risk.